Engbers Luuk H, van Poppel Mireille N M, van Mechelen Willem
Department of Public and Occupational Health, EMGO institute, VU University Medical Center, Amsterdam, The Netherlands.
Prev Med. 2007 Apr;44(4):356-62. doi: 10.1016/j.ypmed.2006.11.005. Epub 2006 Dec 21.
To present the effects of a relatively modest environmental intervention on biological cardiovascular risk indicators.
A controlled trial, including two worksites. Measurements (i.e., body composition, blood pressure and serum cholesterol) took place at baseline and at 3- and 12-month follow-up. The 12-month environmental intervention (The Hague, The Netherlands, 2004) consisted of: a 'Food'-part: to stimulate healthier food choices by means of product information in the canteen, and a 'Steps'-part: focused on stimulating stair use by means of motivational prompts in staircases and on elevator doors.
Significant differences in change between groups (n=540) in favor of the intervention group were found on: [1] total cholesterol for women (-0.35 mmol/l); [2] HDL for men at 3 months (0.05 mmol/l) and 12 months (0.10 mmol/l); and [3] the total-HDL ratio for the total intervention group at 3 and 12 months (-0.45 mmol/l). Both groups showed a decrease in all body composition values at both follow-ups. A significant difference in change in systolic BP was found in favor of the control group (approximately 4 mm Hg), due to an increase in the intervention group at both follow-ups.
Based on the contrasting results, this modest environmental intervention was ineffective in reducing cardiovascular risk in a population of office workers.
呈现相对适度的环境干预对生物心血管风险指标的影响。
一项对照试验,包括两个工作场所。在基线以及随访3个月和12个月时进行测量(即身体成分、血压和血清胆固醇)。12个月的环境干预(2004年于荷兰海牙)包括:“食物”部分:通过食堂的产品信息来刺激更健康的食物选择;以及“步数”部分:通过楼梯间和电梯门上的激励提示来鼓励使用楼梯。
在以下方面发现两组(n = 540)之间的变化存在显著差异,且有利于干预组:[1] 女性的总胆固醇(-0.35 mmol/l);[2] 男性在3个月时的高密度脂蛋白(HDL,0.05 mmol/l)和12个月时的高密度脂蛋白(0.10 mmol/l);以及[3] 整个干预组在3个月和12个月时的总胆固醇与高密度脂蛋白比值(-0.45 mmol/l)。在两次随访中,两组的所有身体成分值均下降。由于干预组在两次随访中均升高,发现收缩压变化存在显著差异,有利于对照组(约4 mmHg)。
基于对比结果,这种适度的环境干预在降低办公室工作人员群体的心血管风险方面无效。